Related Experiment Video
Updated: Aug 22, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Regulation of the Key Epithelial Cancer Suppressor miR-124 Function by Competing Endogenous RNAs
Eleonora A Braga1,2, Marina V Fridman3, Alexey M Burdennyy1
1Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.
Abstract:
A decrease in the miR-124 expression was observed in various epithelial cancers. Like a classical suppressor, miR-124 can inhibit the translation of multiple oncogenic proteins. Epigenetic mechanisms play a significant role in the regulation of miR-124 expression and involve hypermethylation of the MIR-124-1/-2/-3 genes and the effects of long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) according to the model of competing endogenous RNAs (ceRNAs). More than 40 interactomes (lncRNA/miR-124/mRNA) based on competition between lncRNAs and mRNAs for miR-124 binding have been identified in various epithelial cancers. LncRNAs MALAT1, NEAT1, HOXA11-AS, and XIST are the most represented in these axes. Fourteen axes (e.g., SND1-IT1/miR-124/COL4A1) are involved in EMT and/or metastasis. Moreover, eight axes (e.g., OIP5-AS1/miR-124-5p/IDH2) are involved in key pathways, such as Wnt/b-catenin, E2F1, TGF-β, SMAD, ERK/MAPK, HIF-1α, Notch, PI3K/Akt signaling, and cancer cell stemness. Additionally, 15 axes impaired patient survival and three axes reduced chemo- or radiosensitivity. To date, 14 cases of miR-124 regulation by circRNAs have been identified. Half of them involve circHIPK3, which belongs to the exonic ecircRNAs and stimulates cell proliferation, EMT, autophagy, angiogenesis, and multidrug resistance. Thus, miR-124 and its interacting partners may be considered promising targets for cancer therapy.
Insights
MicroRNA-124 (miR-124) acts as a tumor suppressor by inhibiting oncogenic proteins in epithelial cancers. Its dysregulation involves epigenetic changes and interactions with long non-coding RNAs and circular RNAs, offering therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- MicroRNA-124 (miR-124) expression is decreased in various epithelial cancers, where it functions as a tumor suppressor.
- miR-124 inhibits the translation of multiple oncogenic proteins, playing a critical role in cancer progression.
Purpose of the Study:
- To investigate the regulatory mechanisms of miR-124 expression in epithelial cancers.
- To explore the role of competing endogenous RNAs (ceRNAs) involving long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) in miR-124-mediated cancer pathways.
- To identify potential therapeutic targets based on miR-124 interactions.
Main Methods:
- Bioinformatic analysis and literature review to identify lncRNA/miR-124/mRNA and circRNA/miR-124/mRNA interactions (ceRNA networks).
- Analysis of identified axes for involvement in cancer hallmarks like epithelial-mesenchymal transition (EMT), metastasis, signaling pathways, and patient outcomes.
- Review of studies detailing miR-124 regulation by circRNAs, including circHIPK3.
Main Results:
- Epigenetic mechanisms, including gene hypermethylation and ceRNA networks, significantly regulate miR-124 expression.
- Over 40 lncRNA/miR-124/mRNA interactomes were identified, with MALAT1, NEAT1, HOXA11-AS, and XIST being prominent.
- Specific axes are linked to EMT, metastasis, key cancer signaling pathways (Wnt/β-catenin, TGF-β, etc.), stemness, impaired survival, and chemoresistance.
- 14 circRNA regulations of miR-124 were found, with circHIPK3 implicated in proliferation, EMT, and drug resistance.
Conclusions:
- Dysregulation of miR-124, influenced by epigenetic factors and complex ceRNA networks, is crucial in epithelial cancers.
- Identified miR-124 interacting partners and pathways represent promising therapeutic targets for cancer treatment.
- Further research into miR-124-based therapies holds significant potential for improving patient outcomes.
Related Concept Videos
MicroRNAs
Experimental RNAi
lncRNA - Long Non-coding RNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Negative Regulator Molecules
Regulation of Expression at Multiple Steps

